Security key
761330109
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 83,208,743
- Total 13F value
- $409,387,692
- Share change
- +10,713,240
- Put/Call ratio
- 65%
- SEC-reported price per share
- $4.92
- Number of holders
- 182
- Value change
- +$36,028,524
- Number of buys
- 98
- Number of sells
- 90
- Shares outstanding
- 104,661,494
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
182
Top holders
10
RVNC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Revance Therapeutics, Inc. SEC filings
Revance Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761330109
Recent filing periods:
Ownership snapshot
Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Comparable ownership
Top 5
Capital World Investors
11%
BlackRock Finance, Inc.
7.1%
Palo Alto Investors LP
5%
VANGUARD GROUP INC
4.8%
FRANKLIN RESOURCES INC
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital World Investors |
13F
Company
|
11%
|
$104,944,478
11,939,076 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
7.1%
|
$65,515,131
7,453,371 shares
|
— | 31 Dec 2023 |
| Palo Alto Investors LP |
13F
Company
|
5%
|
$46,035,726
5,237,284 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
4.8%
|
$44,562,004
5,069,625 shares
|
— | 31 Dec 2023 |
| FRANKLIN RESOURCES INC |
13F
Company
|
4.5%
|
$41,748,450
4,749,539 shares
|
— | 31 Dec 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
4.4%
|
$40,815,652
4,643,419 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
182
Shares
83,208,743
Rows available
182
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
188
Q1 2024 holders
182
Holder diff
-6
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend